BETA DRUGS
|
BETA DRUGS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹54 Cr | ₹62 Cr | ₹49 Cr | ₹41 Cr | ₹34 Cr |
| Adjustment | ₹9.88 Cr | ₹-6.37 Cr | ₹-4.25 Cr | ₹2.02 Cr | ₹5.10 Cr |
| Changes In working Capital | ₹-27 Cr | ₹-19 Cr | ₹-14 Cr | ₹-20 Cr | ₹-9.77 Cr |
| Cash Flow after changes in Working Capital | ₹37 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹30 Cr |
| Cash Flow from Operating Activities | ₹37 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹30 Cr |
| Cash Flow from Investing Activities | ₹-51 Cr | ₹-36 Cr | ₹-14 Cr | ₹-19 Cr | ₹-22 Cr |
| Cash Flow from Financing Activities | ₹-8.07 Cr | ₹118 Cr | ₹-7.49 Cr | ₹-2.47 Cr | ₹-0.97 Cr |
| Net Cash Inflow / Outflow | ₹-22 Cr | ₹118 Cr | ₹9.47 Cr | ₹1.84 Cr | ₹6.90 Cr |
| Opening Cash & Cash Equivalents | ₹147 Cr | ₹29 Cr | ₹19 Cr | ₹17 Cr | ₹10 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹125 Cr | ₹147 Cr | ₹29 Cr | ₹19 Cr | ₹17 Cr |
Compare Cashflow Statement of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,958.3 Cr | -2.9% | 6% | 8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -2.9% |
6% |
8.2% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses